Denko Group Names Coleman as New CFO
The Denko Group is pleased to announce the appointment of Mr. Adam Coleman as Chief Financial Officer effective immediately. In his new position, Mr. Coleman will be responsible for the administration of the company’s fiduciary affairs as well as corporate compliance.
Singapore, Singapore, September 18, 2010 --(PR.com)-- Mr. Coleman possesses a broad experience in finance, corporate governance, and brings a strong business understanding of global finances. He will be an important addition to the Denko Group and a key contributor behind the execution of the firm’s corporate strategy.
Denko Group is a private equity firm dedicated to providing superior returns on capital. They seek high net return opportunities in all sectors, from high-growth technology and life science companies to recommending competitors funds, while achieving superior returns for investors. They bring together the financial and intellectual capital necessary to create a sharp edge that is focused solely on investor’s confident assurances of outstanding performance. For more information on the Denko Group please visit their website at denkogroup.com.
You should not do, or refrain from doing, anything based on the information provided in this release without first obtaining professional advice from your financial advisor. Denko Group believes the information in this release is correct, and it has reasonable grounds for any opinion or recommendation found within, as at the date the relevant part of this release was last updated. However, Denko Group and its directors, employees and agents are not liable for any loss or damage incurred by any person as a result of any error in any information, opinion or recommendation in this release. Nothing in this release is, or should be taken as, an offer, invitation or recommendation to buy or sell any investment in or make any deposit with Denko Group or any other person.
###
Denko Group is a private equity firm dedicated to providing superior returns on capital. They seek high net return opportunities in all sectors, from high-growth technology and life science companies to recommending competitors funds, while achieving superior returns for investors. They bring together the financial and intellectual capital necessary to create a sharp edge that is focused solely on investor’s confident assurances of outstanding performance. For more information on the Denko Group please visit their website at denkogroup.com.
You should not do, or refrain from doing, anything based on the information provided in this release without first obtaining professional advice from your financial advisor. Denko Group believes the information in this release is correct, and it has reasonable grounds for any opinion or recommendation found within, as at the date the relevant part of this release was last updated. However, Denko Group and its directors, employees and agents are not liable for any loss or damage incurred by any person as a result of any error in any information, opinion or recommendation in this release. Nothing in this release is, or should be taken as, an offer, invitation or recommendation to buy or sell any investment in or make any deposit with Denko Group or any other person.
###
Contact
Denko Group
Brendon MacDonald
+65 6248 4561
denkogroup.com
Fax: +65 6248 4918
Brendon MacDonald
+65 6248 4561
denkogroup.com
Fax: +65 6248 4918
Contact
Categories